Discover how Illumina TruPath Genome paired with DRAGEN v4.5 delivers phased variant calls that outperform long-read sequencing — phasing up to 98% of genes (HMW input) with phase blocks spanning millions of bases. TruPath also achieves 99.41% F1 small variant accuracy, haplotype-resolved calling in 15 high-homology biologically relevant genes, 94% F1 for structural variants greater-than 50 bp, and enhanced STR length estimation. This video is a clip from the full DRAGEN v4.5 webinar, DRAGEN v4.5 - Expanding Accurate Variant Discovery Across the Entire Genome. Watch the full on-demand session here: https://www.illumina.com/events/webinar/2026/dragen-v4.5.html 🔬 Try DRAGEN for free: https://www.illumina.com/destination/dragen-demo.html Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc #Illumina #DRAGEN #TruPath #phasing #structuralvariants #genomics #bioinformatics #ngs For Research Use Only. Not for use in diagnostic procedures.